Testing effectiveness (Phase 2)Study completedNCT03227926
What this trial is testing
Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance
Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 32
Showing 9 of 9 results